Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 28;28(4):2830-2839.
doi: 10.3390/curroncol28040248.

Advancing Academic Cancer Clinical Trials Recruitment in Canada

Affiliations
Review

Advancing Academic Cancer Clinical Trials Recruitment in Canada

Rebecca Y Xu et al. Curr Oncol. .

Abstract

The Canadian Cancer Clinical Trials Network (3CTN) was established in 2014 to address the decline in academic cancer clinical trials (ACCT) activity. Funding was provided to cancer centres to conduct a Portfolio of ACCTs. Larger centres received core funding and were paired with smaller centres to enable support and sharing of resources. All centres were eligible for incentive-based funding for recruitment above pre-3CTN baseline. Established performance measures were collected and tracked. The overall recruitment target was 50% above pre-3CTN baseline by Year 4. An analysis was completed to identify predictive success factors and descriptive statistics were used to summarize site characteristics and outcomes. From 2014-2018, a total of 11,275 patients were recruited to 559 Portfolio trials, an overall increase of 59.6% above pre-3CTN baseline was observed in Year 4. Twenty-five (51%) adult centres met the Year 4 recruitment target and the overall recruitment target was met within three years. Three factors that correlated with sites' achieving recruitment targets were: time period, region and number of baseline trials. 3CTN was successful in meeting its objectives and will continue to support ACCTs and member cancer centres, monitor performance over time and seek continued funding to ensure success, better trial access and outcomes for patients.

Keywords: Canadian cancer clinical trials; academic cancer trials; funding; patient recruitment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
3CTN organizational framework.
Figure 2
Figure 2
Number of active Portfolio trials and patients recruited at adult member institutions. * Member institutions reported recruitment data as of 1 October 2014.
Figure 3
Figure 3
Interaction between core funding and time.

References

    1. Canadian Cancer Research Alliance . Report on the State of Cancer Clinical Trials in Canada. Canadian Cancer Research Alliance; Toronto, ON, Canada: 2011.
    1. Institute of Medicine . A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. The National Academies Press; Washington, DC, USA: 2010. p. 316. - DOI - PubMed
    1. Sharma S., Wells J.C., Hopman W.M., Del Paggio J.C., Gyawali B., Hammad N., Hay A.E., Booth C.M. Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials. Curr. Oncol. 2021;28:1518–1527. doi: 10.3390/curroncol28020143. - DOI - PMC - PubMed
    1. Yusuf S., Cairns J. The perilous state of independent randomized clinical trials and related applied research in Canada. Can. Med. Assoc. J. 2012;184:1997–2002. doi: 10.1503/cmaj.110598. - DOI - PMC - PubMed
    1. DeMets D.L., Califf R.M. A historical perspective on clinical trials innovation and leadership: Where have the academics gone? JAMA. 2011;305:713–714. doi: 10.1001/jama.2011.175. - DOI - PubMed

Publication types